|
|
|
Volumn 23, Issue 8, 2009, Pages 680-681
|
|
HIV therapy may be given safely in resource-limited settings without routine laboratory monitoring.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
DRUG DERIVATIVE;
PHOSPHONIC ACID DERIVATIVE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
TENOFOVIR;
CHEMICALLY INDUCED DISORDER;
DIAGNOSTIC TEST;
DRUG EFFECT;
ECONOMICS;
GLOMERULUS FILTRATION RATE;
HEALTH CARE PLANNING;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INCIDENCE;
KIDNEY DISEASE;
LABORATORY;
NOTE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
TREATMENT OUTCOME;
UGANDA;
VIROLOGY;
ZIMBABWE;
ADENINE;
ANTI-HIV AGENTS;
DIAGNOSTIC TESTS, ROUTINE;
GLOMERULAR FILTRATION RATE;
HEALTH RESOURCES;
HIV INFECTIONS;
HIV-1;
HUMANS;
INCIDENCE;
KIDNEY DISEASES;
LABORATORIES;
PHOSPHONIC ACIDS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
REVERSE TRANSCRIPTASE INHIBITORS;
TREATMENT OUTCOME;
UGANDA;
ZIMBABWE;
|
|
EID: 80053181112
PISSN: None
EISSN: 15577449
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|